About Us Your Partners Team Portfolio News & Events Contact Us òáøéú
    > News 2010
News 2009
    > News 2008
    > News 2007
News 2009
Rewalk, Argo Medical Technologies invention, wins 2009 Popular Science Invention Award
May 11, 2009

The 2009 Popular ScienceInvention Awards

New York, NYMay11, 2009Popular Science honors 10 stunning homebuilt inventions and the big-thinking geniuses who developed them. PopSci celebrates the spirit of invention by bestowing these projects, which have the capacity to change lives and the world, with an Invention Award. The June issue of Popular Science is on newsstands now.

“Creative inventions have the potential to radically change our lives,” says Mark Jannot, editor-in-chief of Popular Science. “The 10 standout inventors we’re honoring have all created unexpected innovations that have the ability to shape our future, and I suspect we’ll see the positive effects of these products often in the very near future.”

PopSci Invention Award winners include ReWalk - Wearable Exoskeleton That Allows Paraplegics to Walk. Confined to a wheelchair after breaking his neck in a 1997 fall, Israeli engineer Amit Goffer developed the only wearable exoskeleton that allows paraplegics to stand, walk, and even climb stairs. 

For more, please see the June issue or visit: http://www.popsci.com/scitech/article/2009-05/robo-legs


Story Text:
 
 
Invention Awards: Robo-Legs
An exoskeleton that enables paraplegics to walk

After breaking his neck in a 1997 fall, Israeli engineer Amit Goffer learned that he would be confined to a wheelchair for the rest of his life. He soon concluded that this mode of transportation was outdated and began work on the ReWalk, the only wearable exoskeleton that allows paraplegics to stand, amble, and even climb stairs. Soon, more than a dozen patients in the U.S. will strap in and start strolling.

Invention: ReWalk
Inventor: Amit Goffer
Cost: $2 million+
Time: 10 years
Is It Ready Yet? 1 2 3 4 5

Goffer, now 56, needed a design that would be not only safe but also energy-efficient enough to last for an entire day. "I was worried you would need a truckload of batteries," he recalls. To solve that problem, he made a design choice that meant he could never use it. Goffer is paralyzed from the chest down, but he realized that if wearers could use crutches, it would conserve energy and simplify balance, since the device wouldn't have to keep the person upright all on its own.

The 44-pound prototype, which takes just a few minutes to get into, has several modes—among them, walking, sitting, and climbing/descending stairs—that the user selects on a wristband controller. Plant one of the crutches and lean forward in walk mode, for example, and a tilt sensor in the ReWalk's shoulder harness registers the motion. A computer in a backpack interprets this data and instructs electric motors in the hip and knee of one leg to move it forward. (Other exoskeletons, like Honda's walking-assist device, take cues from users' actual leg motions or electrical signals in their muscles, which wouldn't work with paraplegics.) Another plant of the crutches and another lean, and the motors on the other side swing the second leg ahead. Stand up straight, and the
device halts.

Like the crutches, many of the components, including the motors and battery pack, are off-the-shelf. Goffer says it's the control algorithms that make the difference. For example, early in the ReWalk's development, he and his team found that the tilt sensor could be thrown off by variations in the way users dressed (for example, its angle could be changed if a user wore a large belt buckle underneath the harness), so they wrote software that accounts for those differences and corrects them. The code also has to filter out vibrations from the ground, initiate the most energy-efficient steps so the batteries don't drain prematurely, quickly recognize a stumble and recover in time to prevent a fall, and more.

Goffer says the next version will be down to about 30 pounds. Several patients have already tested the prototype successfully abroad, and U.S. clinical trials are set to start soon. One of ReWalk's testers, 41-year-old paraplegic Radi Kaiof, thinks patients will be satisfied. When strapped in, he says, "I speak eye-to-eye with people, not from the bottom up. There is one life in a wheelchair, and this is a new life."
Back to top
Your Partners
Venture Capital Israel | VC Funds Israel | Early Stage Investment Israel | Israel Technology Incubator
Seed Investment Israel | ÷éãåí àúøéí | çîîä èëðåìåâéú | ÷øðåú äåï ñéëåï | øòéåï èëðåìåâé | äù÷òåú ñéã áéùøàì .